Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons

DNA and Cell Biology

Volumn 30, Issue 12, 2011, Pages 965-974

  Sarojini, Sreeja ^a   Theofanis, Thana ^a,d   Reiss, Carol Shoshkes ^a,b,c  

^a NEW YORK UNIVERSITY   (United States)

^b Center for Neural Science   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERFERON INDUCING AGENT; MESSENGER RNA; SHORT HAIRPIN RNA; TETHERIN PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENETIC TRANSFECTION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RHABDOVIRUS INFECTION; VESICULAR STOMATITIS VIRUS; VIRUS RELEASE;

ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL MEMBRANE; CELL SHAPE; GENE EXPRESSION REGULATION; INTERFERON-BETA; INTERFERON-GAMMA; L CELLS (CELL LINE); MEMBRANE GLYCOPROTEINS; MICE; NEUROBLASTOMA; NEURONS; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; VESICULAR STOMATITIS INDIANA VIRUS; VIRUS REPLICATION;

EID: 82955187052     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1384     Document Type: Article

References (85)

1. Akira, S. (2006). TLR signaling. Curr Top Microbiol Immunol 311, 1-16. (Pubitemid 47413193)
2. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801. (Pubitemid 43261452)
3. Bartee, E., McCormack, A., and Fruh, K. (2006). Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2, e107.
4. Baum, A., and Garcia-Sastre, A. (2010). Induction of type I in-terferon by RNA viruses: cellular receptors and their substrates. Amino Acids 38, 1283-1299.
5. Blasius, A.L., Giurisato, E., Cella, M., Schreiber, R.D., Shaw, A.S., and Colonna, M. (2006). Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 177, 3260-3265. (Pubitemid 44277845)
6. Breakfield, X.O., Neale, E.A., Neale, J.H., and Jacobowitz, D.M. (1975). Localized catecholamine storage associated with granules in murine neuroblastoma cells. Brain Res 92, 237-256.
7. Cao, W., Bover, L., Cho, M., Wen, X., Hanabuchi, S., Bao, M., et al. (2009). Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med 206, 1603-1614.
8. Casartelli, N., Sourisseau, M., Feldmann, J., Guivel-Benhassine, F., Mallet, A., Marcelin, A.G., et al. (2010). Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog 6, e1000955.
9. Chauhan, V.S., Furr, S.R., Sterka, D.G., Jr., Nelson, D.A., Moerdyk-Schauwecker, M., Marriott, I., et al. (2010). Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses. Virology 400, 187-196.
10. Chesler, D.A., McCutcheon, J.A., and Reiss, C.S. (2004). Post-transcriptional regulation of neuronal nitric oxide synthase expression by IFN-gamma. J Interferon Cytokine Res 24, 141-149. (Pubitemid 38253641)
11. Chesler, D.A., Munoz-Jordan, J.L., Donelan, N., Garcia-Sastre, A., and Reiss, C.S. (2003). PKR is not required for interferon-gamma inhibition of VSV replication in neurons. Viral Immunol 16, 87-96. (Pubitemid 36427742)
12. Chesler, D.A., and Reiss, C.S. (2002). The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev 13, 441-454. (Pubitemid 35303815)
13. D'Agostino, P.M., Amenta, J.J., and Reiss, C.S. (2009a). IFN-beta-induced alteration of VSV protein phosphorylation in neuro-nal cells. Viral Immunol 22, 353-369.
14. D'Agostino, P.M., Yang, J., and Reiss, C.S. (2009b). Distinct mechanisms of inhibition of VSV replication in neurons mediated by type I and type II IFN. Virus Rev Res 14, 20-29.
15. D'Agostino, P.M., and Reiss, C.S. (2010). A confocal and electron microscopic comparison of interferon beta-induced changes in vesicular stomatitis virus infection of neuroblastoma and nonneuronal cells. DNA Cell Biol 29, 103-120.
16. Dietrich, I., McMonagle, E.L., Pelit, S.J., Vijayakrishnan, S., Logan, N., Chari, C.N., et al. (2001). Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. J Virol 85, 5840-5852.
17. Dube, M., Roy, B.B., Guiot-Guillain, P., Binette, J., Mercier, J., Chiasson, A., et al. (2010). Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog 6, e1000856.
18. Durbin, J.E., Hackenmiller, R., Simon, M.C., and Levy, D.E. (1996). Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450. (Pubitemid 26058569)
19. Evans, D.T., Serra-Moreno, R., Singh, R.K., and Guatelli, J.C. (2010). BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol 18, 388-396.
20. Georgel, P., Jiang, Z., Kunz, S., Janssen, E., Mols, J., Hoebe, K., et al. (2007). Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362, 304-313. (Pubitemid 46678142)
21. Goodbourn, S., Didcock, L., and Randall, R.E. (2000). Inter-ferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81, 2341-2364.
22. Groom, H.C., Yap, M.W., Galao, R.P., Neil, S.J., and Bishop, K.N. (2010). Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci USA 107, 5166-5171.
23. Gupta, R.K., Mlcochova, P., Pelchen-Matthews, A., Petit, S.J., Mattiuzzo, G., Pillay, D., et al. (2009). Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc Natl Acad Sci USA 106, 20889-20894.
24. Haller, O., Kochs, G., and Weber, F. (2007). Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev 18, 425-433. (Pubitemid 47302821)
25. Hammonds, J., and Spearman, P. (2009). Tetherin is as tetherin does. Cell 139, 456-457.
26. Hinz, A., Miguet, N., Natrajan, G., Usami, Y., Yamanaka, H., Renesto, P., et al. (2010). Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain. Cell Host Microbe 7, 314-323.
27. Huneycutt, B.S., Bi, Z., Aoki, C.J., and Reiss, C.S. (1993). Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J Virol 67, 6698-6706. (Pubitemid 23309138)
28. Hwang, S.Y., Hertzog, P.J., Holland, K.A., Sumarsono, S.H., Tymms, M.J., Hamilton, J.A., et al. (1995). A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to inter-ferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci USA 92, 11284-11288.
29. Ireland, D.D., Palian, B.M., and Reiss, C.S. (2005). Interleukin (IL)-12 receptor beta1 or IL-12 receptor beta 2 deficiency in mice indicates that IL-12 and IL-23 are not essential for host recovery from viral encephalitis. Viral Immunol 18, 397-402. (Pubitemid 41106019)
30. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I.B., et al. (2009). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 5, e1000429.
31. Jolly, C., Booth, N.J., and Neil, S.J. (2010). Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. J Virol 84, 12185-12199.
32. Jouvenet, N., Neil, S.J., Zhadina, M., Zang, T., Kratovac, Z., Lee, Y., et al. (2009). Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 83, 1837-1844.
33. Kaletsky, R.L., Francica, J.R., Agrawal-Gamse, C., and Bates, P. (2009). Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci USA 106, 2886-2891.
34. Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., et al. (2008). Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205, 1601-1610. (Pubitemid 351962024)
35. Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., et al. (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105.
36. Kawai, S., Azuma, Y., Fujii, E., Furugaki, K., Ozaki, S., Matsu-moto, T., et al. (2008). Interfeson-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models. Cancer Sci 99, 2461-2466.
37. Kuhl, B.D., Cheng, V., Wainberg, M.A., and Liang, C. (2011). Tetherin and its viral antagonists. J Neuroimmune Pharmacol 6, 188-201.
38. Kumagai, Y., Takeuchi, O., and Akira, S. (2008). Pathogen recognition by innate receptors. J Infect Chemother 14, 86-92. (Pubitemid 351624472)
39. Le Tortorec, A., and Neil, S.J. (2009). Antagonism to and intra-cellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 83, 11966-11978.
40. Levy, D.E., and Darnell, J.E., Jr. (2002). Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3, 651-662. (Pubitemid 34987786)
41. Levy, D.E., and Garcia-Sastre, A. (2001). The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 12, 143-156. (Pubitemid 32590836)
42. Lopez, L.A., Yang, S.J., Hauser, H., Exline, C.M., Haworth, K.G., Oldenburg, J., et al. (2010). Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J Virol 84, 7243-7255.
43. Mansouri, M., Viswanathan, K., Douglas, J.L., Hines, J., Gustin, J., Moses, A.V., et al. (2009). Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J Virol 83, 9672-9681.
44. Meraz, M.A., White, J.M., Sheehan, K.C., Bach, E.A., Rodig, S.J., Dighe, A.S., et al. (1996). Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442. (Pubitemid 26058568)
45. Miyagi, E., Andrew, A.J., Kao, S., and Strebel, K. (2009). Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci USA 106, 2868-2873.
46. Miyakawa, K., Ryo, A., Murakami, T., Ohba, K., Yamaoka, S., Fukuda, M., et al. (2009). BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction. PLoS Pathog 5, e1000700.
47. Negishi, H., Fujita, Y., Yanai, H., Sakaguchi, S., Ouyang, X., Shinohara, M., et al. (2006). Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci USA 103, 15136-15141. (Pubitemid 44583177)
48. Neil, S.J., Sandrin, V., Sundquist, W.I., and Bieniasz, P.D. (2007). An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2, 193-203. (Pubitemid 47355204)
49. Neil, S.J., Zang, T., and Bieniasz, P.D. (2008). Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430. (Pubitemid 351158893)
50. Ohtomo, T., Sugamata, Y., Ozaki, Y., Ono, K., Yoshimura, Y., Kawai, S., et al. (1999). Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun 258, 583-591. (Pubitemid 29290312)
51. Olitsky, P.K., Cox, H.R., and Syverton, J.T. (1933). Infection in mice following instillation of Vesicular Stomatitis virus. Science 77, 611-612.
52. Pardieu, C., Vigan, R., Wilson, S.J., Calvi, A., Zang, T., Bieniasz, P., et al. (2010). The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog 6, e1000843.
53. Perez-Caballero, D., Zang, T., Ebrahimi, A., McNatt, M.W., Gregory, D.A., Johnson, M.C., et al. (2009). Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139, 499-511.
54. Pestka, S., Krause, C.D., and Walter, M.R. (2004). Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202, 8-32. (Pubitemid 39576902)
55. Pichlmair, A., and Reise Sousa, C. (2007). Innate recognition of viruses. Immunity 27, 370-383. (Pubitemid 47418682)
56. Plakhov, I.V., Arlund, E.E., Aoki, C., and Reiss, C.S. (1995). The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209, 257-262.
57. Reiss, C.S. (2009). VSV infection elicits distinct host responses in the periphery and the brain. In RNA Viruses: Host Gene Responses to Infection. Yang, D., ed. (World Scientific Publishing, Hackensack, NJ), pp. 229-246.
58. Roberts, R.M., Ezashi, T., Rosenfeld, C.S., Ealy, A.D., and Ku-bisch, H.M. (2003). Evolution of the interferon tau genes and their promoters, and maternal-trophoblast interactions in control of their expression. Reprod Suppl 61, 239-251.
59. Robin, J., Lariviere-Durand, C., and Berthiaume, L. (1982). Plaque assay of bluegill virus using a methylcellulose overlay. J Virol Methods 5, 351-354. (Pubitemid 13221634)
60. Rollason, R., Korolchuk, V., Hamilton, C., Jepson, M., and Banting, G. (2009). A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. J Cell Biol 184, 721-736.
61. Rollason, R., Korolchuk, V., Hamilton, C., Schu, P., and Banting, G. (2007). Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J Cell Sci 120, 3850-3858. (Pubitemid 350187366)
62. Rong, L., Zhang, J., Lu, J., Pan, Q., Lorgeoux, R.P., Aloysius, C., et al. (2009). The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol 83, 7536-7546.
63. Rose, J.K., and Whitt, M.A. (2001). Rhabdoviridae: the viruses and their replication. In Fields Virology. D.M. Knipe and P.M. Howley, eds. (Lippincott, Williams & Wilkins, Philadephia, PA), pp. 1221-1244.
64. Sadler, A.J., and Williams, B.R. (2008). Interferon-inducible antiviral effectors. Nat Rev Immunol 8, 559-568. (Pubitemid 351913674)
65. Sakuma, T., Noda, T., Urata, S., Kawaoka, Y., and Yasuda, J. (2009). Inhibition of Lassa and Marburg virus production by tetherin. J Virol 83, 2382-2385.
66. Samuel, C.E. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14, 778-809. (Pubitemid 32979631)
67. Sato, K., Yamamoto, S.P., Misawa, N., Yoshida, T., Miyazawa, T., and Koyanagi, Y. (2009). Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species. Retrovirology 6, 53.
68. Sauter, D., Specht, A., and Kirchhoff, F. (2010). Tetherin: holding on and letting go. Cell 141, 392-398.
69. Schubert, D., Humphreys, S., Baroni, C., and Cohn, M. (1969). In vitro differentiation of a mouse neuroblastoma. Proc Natl Acad Sci USA 64, 316-323.
70. Schubert, H.L., Zhai, Q., Sandrin, V., Eckert, D.M., Garcia-Maya, M., Saul, L., et al. (2010). Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc Natl Acad Sci USA 107, 17951-17956.
71. Stojdl, D.F., Lichty, B., Knowles, S., Marius, R., Atkins, H., So-nenberg, N., et al. (2000). Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6, 821-825. (Pubitemid 30469434)
72. Sugiyama, Y., Odaka, H., Itokawa, S., Ishikawa, E., Tomari, Y., and Ikeda, H. (1995). TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters. Atherosclerosis 118, 145-153.
73. Takeuchi, O., and Akira, S. (2008). MDA5/RIG-I and virus recognition. Curr Opin Immunol 20, 17-22.
74. Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation. Cell 140, 805-820.
75. Trottier, M.D., Jr., Palian, B.M., and Reiss, C.S. (2005). VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 333, 215-225. (Pubitemid 40253591)
76. Trottier, M.D., Lyles, D.S., and Reiss, C.S. (2007). Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection. J Neurovirol 13, 433-445. (Pubitemid 350104390)
77. Van Damme, N., Goff, D., Katsura, C., Jorgenson, R.L., Mitchell, R., Johnson, M.C., et al. (2008). The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3, 245-252. (Pubitemid 351494713)
78. van Pesch, V., Lanaya, H., Renauld, J.C., and Michiels, T. (2004). Characterization of the murine alpha interferon gene family. J Virol 78, 8219-8228. (Pubitemid 38944305)
79. Versteeg, G.A., and Garcia-Sastre, A. (2010). Viral tricks to gridlock the type I interferon system. Curr Opin Microbiol 13, 508-516.
80. Vidal-Laliena, M., Romero, X., March, S., Requena, V., Petriz, J., and Engel, P. (2005). Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohis-tochemistry. Cell Immunol 236, 6-16. (Pubitemid 41771079)
81. Weidner, J.M., Jiang, D., Pan, X.B., Chang, J., Block, T.M., and Guo, J.T. (2010). Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84, 12646-12657.
82. Wilkins, C., and Gale, M., Jr. (2010). Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 22, 41-47.
83. Xu, F., Tan, J., Liu, R., Xu, D., Li, Y., Geng, Y., et al. (2011). Tetherin Inhibits Prototypic Foamy Virus Release. Virol J 8, 198.
84. Zhang, F., Wilson, S.J., Landford, W.C., Virgen, B., Gregory, D., Johnson, M.C., et al. (2009). Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6, 54-67.
85. Zhang, K.X., Matsui, Y., Hadaschik, B.A., Lee, C., Jia, W., Bell, J.C., et al. (2010). Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death. Int J Cancer 127, 830-838.